Original Article
Development and validation of a deep learning-based model to predict response and survival of T790M mutant non-small cell lung cancer patients in early clinical phase trials using electronic medical record and pharmacokinetic data
Translational Lung Cancer Research
2024;
13
(4)
:706-720
.
(29 April 2024)
CT-based radiomics and clinical characteristics for predicting bone metastasis in lung adenocarcinoma patients
Translational Lung Cancer Research
2024;
13
(4)
:721-732
.
(29 April 2024)
Differential expression of DMD transcripts as a novel prognostic biomarker in histologically diverse mesotheliomas
Translational Lung Cancer Research
2024;
13
(4)
:733-748
.
(29 April 2024)
Effect of histological subtype on the efficacy of perioperative chemotherapy in pulmonary sarcomatoid carcinoma: a retrospective study based on SEER population
Translational Lung Cancer Research
2024;
13
(4)
:749-762
.
(29 April 2024)
Molecular and immune characterization of Chinese early-stage non-squamous non-small cell lung cancer: a multi-omics cohort study
Translational Lung Cancer Research
2024;
13
(4)
:763-784
.
(29 April 2024)
Carrying on with life as a lung cancer survivor: a qualitative study of Australian survivors’ employment, finances, relationships, and healthcare experiences
Translational Lung Cancer Research
2024;
13
(4)
:785-798
.
(29 April 2024)
Clinicopathological characterization of next-generation sequencing detected mutations in lung cancers—a single-center experience
Translational Lung Cancer Research
2024;
13
(4)
:799-810
.
(29 April 2024)
Prolonged survival and novel prognostic factors in women with pleural mesothelioma treated with extended pleurectomy decortication
Translational Lung Cancer Research
2024;
13
(4)
:811-820
.
(29 April 2024)
Impact of lymph node dissection on cancer-specific survival in non-small cell lung cancer patients: a SEER database analysis
Translational Lung Cancer Research
2024;
13
(4)
:821-838
.
(29 April 2024)
Entrectinib as first-line vs. second-line therapy in ROS1 fusion-positive non-small cell lung cancer: a cost-effectiveness analysis
Translational Lung Cancer Research
2024;
13
(4)
:839-848
.
(29 April 2024)
Efficacy of neoadjuvant chemo-immunotherapy in non-small cell lung cancer: a real-world, multicenter, retrospective study
Translational Lung Cancer Research
2024;
13
(4)
:849-860
.
(29 April 2024)
Immunotherapy for patients with advanced non-small cell lung cancer harboring oncogenic driver alterations other than EGFR: a multicenter real-world analysis
Translational Lung Cancer Research
2024;
13
(4)
:861-874
.
(29 April 2024)
Efficacy of targeted therapy in patients with non-small cell lung cancer harboring very rare mutations in EGFR exon 18
Translational Lung Cancer Research
2024;
13
(4)
:875-884
.
(29 April 2024)
Accurate categorization and rapid pathological diagnosis correction with Micro-Raman technique in human lung adenocarcinoma infiltration level
Translational Lung Cancer Research
2024;
13
(4)
:885-900
.
(29 April 2024)
Identifying optimal surgical approach among T1N2–3M0 non-small cell lung cancer patients: a population-based analysis
Translational Lung Cancer Research
2024;
13
(4)
:901-929
.
(29 April 2024)
Editorial Commentary
The evolving treatment landscape for BRAF-mutated non-small cell lung cancer
Translational Lung Cancer Research
2024;
13
(4)
:930-935
.
(29 April 2024)
Antibody-drug conjugate development: opening windows for EGFR-mutant EGFR tyrosine kinase inhibitor-resistant non-small cell lung cancers?
Translational Lung Cancer Research
2024;
13
(4)
:936-939
.
(29 April 2024)
MET targeted therapy in non-small cell lung cancer patients with MET exon 14-skipping mutations
Translational Lung Cancer Research
2024;
13
(4)
:940-946
.
(29 April 2024)
Subcutaneous delivery of immune checkpoint inhibitors: new route replacing intravenous administration?
Translational Lung Cancer Research
2024;
13
(4)
:947-951
.
(29 April 2024)
The heterogenous landscape of EGFR Del19 mutation subtype: not all are the same for osimertinib
Translational Lung Cancer Research
2024;
13
(4)
:952-955
.
(29 April 2024)
Small cell, big promises: targeting small cell lung cancer with CAR T cells
Translational Lung Cancer Research
2024;
13
(4)
:956-960
.
(29 April 2024)
